A site-specific analysis showed that after this date there were significant reductions of 73% for fatal cancers of the respiratory and intrathoracic organs; 78% for lymphatic and haemopoetic cancer, 49% for genitourinary cancers, and a borderline significant reduction of 39% for digestive and peritoneal cancers.
← all excerpts
Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.
1
—
—